{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:26:34Z","timestamp":1776065194885,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001700","name":"the Ministry of Education, Science, Sports, and Culture in Japan","doi-asserted-by":"crossref","award":["\u115f"],"award-info":[{"award-number":["\u115f"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13045-015-0201-x","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T02:50:02Z","timestamp":1441248602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical significance of high-dose cytarabine added to cyclophosphamide\/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy"],"prefix":"10.1186","volume":"8","author":[{"name":"on behalf of the AML and MDS Working Group of the Japan Society for Hematopoietic Cell Transplantation","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Iwato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Takami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,4]]},"reference":[{"key":"201_CR1","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1200\/JCO.2010.28.8852","volume":"28","author":"M Duval","year":"2010","unstructured":"Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730\u20138.","journal-title":"J Clin Oncol"},{"key":"201_CR2","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1200\/JCO.2013.48.8114","volume":"31","author":"A Nagler","year":"2013","unstructured":"Nagler A, Rocha V, Labopin M, Unal A, Ben Othman T, Campos A, et al. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen\u2014a report from the acute leukemia working party of the European group for blood and marrow transplantation. J Clin Oncol. 2013;31:3549\u201356.","journal-title":"J Clin Oncol"},{"key":"201_CR3","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1182\/blood-2013-07-514448","volume":"122","author":"EA Copelan","year":"2013","unstructured":"Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 2013;122:3863\u201370.","journal-title":"Blood"},{"key":"201_CR4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11912-013-0340-6","volume":"15","author":"J Magenau","year":"2013","unstructured":"Magenau J, Couriel DR. Hematopoietic stem cell transplantation for acute myeloid leukemia: to whom, when, and how. Curr Oncol Rep. 2013;15:436\u201344.","journal-title":"Curr Oncol Rep"},{"key":"201_CR5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1182\/blood-2015-04-642652","volume":"126","author":"Y Arai","year":"2015","unstructured":"Arai Y, Takeda J, Aoki K, Kondo T, Takahashi S, Onishi Y, et al. Efficiency of high-dose cytarabine added to CY\/TBI in cord blood transplantation for myeloid malignancy. Blood. 2015;126:415\u201322.","journal-title":"Blood"},{"key":"201_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.bmt.1705543","volume":"39","author":"Y Inamoto","year":"2007","unstructured":"Inamoto Y, Nishida T, Suzuki R, Miyamura K, Sao H, Iida H, et al. Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation. Bone Marrow Transplant. 2007;39:25\u201330.","journal-title":"Bone Marrow Transplant"},{"key":"201_CR7","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.bbmt.2005.07.005","volume":"11","author":"Y Kanda","year":"2005","unstructured":"Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, et al. Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor. Biol Blood Marrow Transplant. 2005;11:881\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"201_CR8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF03006932","volume":"86","author":"Y Atsuta","year":"2007","unstructured":"Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86:269\u201374.","journal-title":"Int J Hematol"},{"key":"201_CR9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.bbmt.2010.12.702","volume":"17","author":"VT Ho","year":"2011","unstructured":"Ho VT, Kim HT, Aldridge J, Liney D, Kao G, Armand P, et al. Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:1196\u2013204.","journal-title":"Biol Blood Marrow Transplant"},{"key":"201_CR10","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2011-08-372573","volume":"119","author":"J Kanda","year":"2012","unstructured":"Kanda J, Saji H, Fukuda T, Kobayashi T, Miyamura K, Eto T, et al. Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8\/8 allele-matched unrelated transplantation: a nationwide retrospective study. Blood. 2012;119:2409\u201316.","journal-title":"Blood"},{"key":"201_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/1607845412Y.0000000010","volume":"17","author":"Y Arai","year":"2012","unstructured":"Arai Y, Maeda T, Sugiura H, Matsui H, Jo T, Ueda T, et al. Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: retrospective analysis in a single institution. Hematology. 2012;17:207\u201314.","journal-title":"Hematology"},{"key":"201_CR12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11899-013-0156-3","volume":"8","author":"ND Reese","year":"2013","unstructured":"Reese ND, Schiller GJ. High-dose cytarabine (HD araC) in the treatment of leukemias: a review. Curr Hematol Malig Rep. 2013;8:141\u20138.","journal-title":"Curr Hematol Malig Rep"},{"key":"201_CR13","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","volume":"19","author":"Y Arai","year":"2013","unstructured":"Arai Y, Yamashita K, Mizugishi K, Watanabe T, Sakamoto S, Kitano T, et al. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1683\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"key":"201_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/asheducation-2013.1.56","volume":"2013","author":"K Besien van","year":"2013","unstructured":"van Besien K. Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence. Hematology Am Soc Hematol Educ Program. 2013;2013:56\u201362.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"201_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.leukres.2015.03.022","volume":"39","author":"T Konuma","year":"2015","unstructured":"Konuma T, Kato S, Ishii H, Oiwa-Monna M, Asano S, Tojo A, et al. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies. Leuk Res. 2015;39:625\u201331.","journal-title":"Leuk Res"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-015-0201-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T18:50:26Z","timestamp":1498243826000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jhoonline.org\/content\/8\/1\/102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["201"],"URL":"https:\/\/doi.org\/10.1186\/s13045-015-0201-x","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,4]]},"article-number":"102"}}